These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 1105663)

  • 21. [Current status of immunotherapy of malignant tumors].
    Flad HD; Betzler M; Herfarth C
    Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
    [No Abstract]   [Full Text] [Related]  

  • 22. Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants.
    Bast RC; Bast BS
    Ann N Y Acad Sci; 1976; 277(00):60-93. PubMed ID: 826208
    [No Abstract]   [Full Text] [Related]  

  • 23. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
    Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
    Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB; Serrou B
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy of malignancy in humans. Current status.
    Holmes EC; Eilber FR; Morton DL
    JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy in malignant melanomaa.
    Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
    Moff SL; Corey GR; Gottfredsson M
    Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
    [No Abstract]   [Full Text] [Related]  

  • 30. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
    Bennett JA; Gruft H; McKneally MF; Zelterman D; Crispen RG
    Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunological aspects of malignant disease.
    Oliver RT
    Practitioner; 1975 Apr; 214(1282):511-521. PubMed ID: 49889
    [No Abstract]   [Full Text] [Related]  

  • 33. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME; Brandhorst JS; Hanna MG
    J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy of malignancies: current status.
    Eilber FR; Holmes EC; Morton DL; Ramming KP; Sparks FC
    AJR Am J Roentgenol; 1976 May; 126(5):1088-93. PubMed ID: 178234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 36. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined treatment of syngeneic murine tumors and xenotransplanted human lung cancer by immunotherapy and radiotherapy.
    Terashima H; Yasumoto K; Yanagawa E; Takayama K; Nomoto K; Azuma I; Yamamura Y
    Gan; 1981 Jun; 72(3):363-9. PubMed ID: 7033032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some immunologically based reactions that can cause the regression of large tumor masses.
    Alexander P
    Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.